Education
About Us
Working with TipRanks
Follow Us
Scienture Holdings (SCNX)
NASDAQ:SCNX
SCNX Stock Chart & Stats
$0.55
-$0.13(-2.47%)
At close: 4:00 PM EST
$0.55
-$0.13(-2.47%)
Day’s Range― - ―
52-Week Range$0.39 - $3.61
Previous CloseN/A
Volume1.53K
Average Volume (3M)4.08M
Market Cap
$17.59M
Enterprise Value$7.89M
Total Cash (Recent Filing)$355.69K
Total Debt (Recent Filing)$2.02M
Price to Earnings (P/E)―
Beta3.63
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-11.60
Shares Outstanding40,630,814
10 Day Avg. Volume11,411,402
30 Day Avg. Volume4,082,790
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.26
Price to Sales (P/S)149.45
P/FCF Ratio-1.43
Enterprise Value/Market Cap0.45
Enterprise Value/Revenue12.08
Enterprise Value/Gross Profit14.02
Enterprise Value/Ebitda-0.48
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross Margin And TTM Revenue ReboundVery high gross margins combined with a sharp TTM revenue rebound indicate strong unit economics on the company's offerings. If sustained, these margins provide structural leverage as revenue scales, improving long-run operating leverage and making profitable growth more achievable once fixed costs are controlled.
Diversified, Recurring Revenue ChannelsA mix of subscription software licensing, consulting fees, milestone payments and partnerships creates diversified revenue streams and recurring elements. This business model reduces single-customer concentration risk and supports steadier revenue visibility and customer stickiness over a multi-month horizon.
Expanded Equity Distribution AgreementRaising the capacity under the equity distribution agreement materially increases near-term financing optionality. This structural enhancement to capital access reduces short-term funding stress and gives management more flexibility to fund R&D, operations, or partnerships without immediate reliance on bank debt.
Bears Say
Persistent Negative Operating And Free Cash FlowSustained negative operating and free cash flow signals the business is not funding operations internally, forcing reliance on external capital. Over months this raises execution and dilution risk, constrains reinvestment, and limits runway for commercial expansion absent reliable financing sources.
Large Operating Losses Relative To SalesVery large operating losses versus a small revenue base undermine the trajectory to sustainable profitability. This structural earnings gap reduces financial resilience, weakens return on invested capital, and increases the risk that future growth will require ongoing subsidization by new capital.
Nasdaq Minimum Bid Price Non-compliance RiskA Nasdaq bid-price non-compliance notice is a structural governance and liquidity risk: potential delisting or remediation actions can reduce investor access and liquidity, distract management, and make future capital raises more difficult, affecting strategic execution over months.
Scienture Holdings News
SCNX FAQ
What was Scienture Holdings’s price range in the past 12 months?
Scienture Holdings lowest stock price was $0.39 and its highest was $3.61 in the past 12 months.
What is Scienture Holdings’s market cap?
Scienture Holdings’s market cap is $17.59M.
When is Scienture Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Scienture Holdings’s earnings last quarter?
Scienture Holdings released its earnings results on Jul 22, 2024. The company reported -$1.304 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.304.
Is Scienture Holdings overvalued?
According to Wall Street analysts Scienture Holdings’s price is currently Overvalued.
Does Scienture Holdings pay dividends?
Scienture Holdings pays a Notavailable dividend of $1.5 which represents an annual dividend yield of N/A. See more information on Scienture Holdings dividends here
What is Scienture Holdings’s EPS estimate?
Scienture Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scienture Holdings have?
Scienture Holdings has 40,630,814 shares outstanding.
What happened to Scienture Holdings’s price movement after its last earnings report?
Scienture Holdings reported an EPS of -$1.304 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.634%.
Which hedge fund is a major shareholder of Scienture Holdings?
Currently, no hedge funds are holding shares in SCNX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Scienture Holdings
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
Technical Analysis
Ownership Overview
―
Insiders
0.23% Mutual Funds
<0.01% Other Institutional Investors
98.77% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---